Home
About
Overview
Sharing Data
ORCID
Help
History (60)
Papilloma, Inverted
Adrenergic Uptake Inhibitors
Developing an urban community-campus partnership: lessons learned in infrastructure development and communication.
The Moonshot Initiative: Randomized, Controlled Trials, and Its Impact in Pediatric Oncology.
Soluble a-synuclein is a novel modulator of Alzheimer's disease pathophysiology.
See All 60 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Soluble a-synuclein is a novel modulator of Alzheimer's disease pathophysiology.
Soluble a-synuclein is a novel modulator of Alzheimer's disease pathophysiology. J Neurosci. 2012 Jul 25; 32(30):10253-66.
View in:
PubMed
subject areas
Aged
Aged, 80 and over
alpha-Synuclein
Alzheimer Disease
Amyloid beta-Peptides
Animals
Cognitive Dysfunction
Disease Models, Animal
Humans
Maze Learning
Mice
Mice, Transgenic
Nerve Fibers, Unmyelinated
Neurons
Neuropsychological Tests
Presenilin-1
tau Proteins
Temporal Lobe
authors with profiles
David A Bennett
Julie A Schneider